Patient handout for A&E staff who are not aware of aspergillosis.
What is CPA?
CPA is a chronic fungal infection of the lungs caused by Aspergillus, most often in people who already have damaged lungs from conditions like tuberculosis, COPD, lung cancer, or sarcoidosis.
Unlike ABPA, CPA is a true infection, not an allergic reaction. It is not contagious but can slowly destroy lung tissue if not treated.
Symptoms
-
Chronic cough, often with mucus
-
Coughing up blood (haemoptysis)
-
Fatigue, low-grade fever
-
Unexplained weight loss
-
Breathlessness
-
Recurrent chest infections not responding to antibiotics
Diagnosis
-
CT scan of the chest showing cavities, nodules, or fungus balls (aspergillomas)
-
Aspergillus IgG antibody (usually raised)
-
Positive sputum PCR or culture for Aspergillus
-
Exclude TB and malignancy
Treatment
-
Long-term antifungal therapy (e.g. itraconazole, voriconazole, posaconazole)
-
Monitor blood levels and liver function
-
Surgery or embolisation if severe bleeding occurs
-
Supportive care: oxygen, nutrition, physiotherapy
Key Points for A&E:
✅ CPA is a progressive fungal infection, not a typical bacterial pneumonia
✅ May present with haemoptysis, respiratory distress, or systemic illness
✅ Review current antifungal treatment and potential drug interactions
✅ Consider urgent chest CT and specialist referral if patient is unwell
📍 For specialist support:
National Aspergillosis Centre (NAC)
🏥 Wythenshawe Hospital, Manchester University NHS Foundation Trust
🌐 NAC homepage on MFT website https://mft.nhs.uk/wythenshawe/services/infectious-diseases/national-aspergillosis-centre/
🌐 www.aspergillosis.org
📞 Daytime contact: 0161 291 2891 or 0161 291 4362
📞 Urgent out-of-hours: Call Wythenshawe switchboard on 0161 998 7070
📢 Ask for the on-call Infectious Diseases Consultant
Share this post
Latest News posts
🧾 Vitamins & Minerals in Aspergillosis: What Patients Should Know
September 25, 2025
🌟 Biologics and the Future: A Toolkit for Severe Asthma, ABPA & Beyond
September 24, 2025
Steroid Use and Your Eyesight: What Patients Need to Know
September 23, 2025
Comparing Health Systems: NHS vs Insurance-Based Models
September 18, 2025
Personality, Connection, and Mental Health
September 17, 2025
Grief and the Loss of Health in Aspergillosis
September 17, 2025
Mannose-Binding Lectin (MBL) Deficiency and Aspergillosis
September 16, 2025
Autumn 2025 COVID-19 Booster – What Aspergillosis Patients Need to Know
September 15, 2025
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
